RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.


Anthony Hickey honored by American Association of Pharmaceutical Scientists

RESEARCH TRIANGLE PARK, NC – Anthony Hickey, Ph.D., a distinguished fellow at RTI International, has been named this year's winner of the David J.W. Grant Research Achievement in Physical Pharmacy award by the American Association of Pharmaceutical Scientists (AAPS).

The award honors Hickey for his groundbreaking research on pharmaceutical aerosols, including drugs and vaccines delivered by inhalers. His work has paved the way for new methods of treatment and prevention of asthma, chronic obstructive pulmonary disease, cystic fibrosis, diabetes, tuberculosis, influenza, diphtheria and hepatitis.

"As a consequence of his findings, several novel technologies have been developed from which products have emerged," the AAPS noted in an announcement of the award.

AAPS President Alice Till presented the award during the annual AAPS meeting recently in Orlando, Florida.

As senior research pharmacologist at RTI, Hickey focuses on improving understanding of the physiology, pharmacology and immunology of the lungs. In addition, he is an emeritus professor of the Eshelman School of Pharmacy and an adjunct professor of biomedical engineering in the School of Medicine at the University of North Carolina at Chapel Hill.

Hickey is a fellow of the American Association for the Advancement of Science, the American Association of Pharmaceutical Scientists and the Society of Biology. He holds 21 patents and has published numerous papers and chapters in pharmaceutical and biomedical topics.